suggest that patients before and after renal nerve ablation should have been investigated off antihypertensive medications or on a standardized treatment regimen. For studies on human physiology, highly standardized conditions are desirable. However, our goal was studying influences of renal nerve ablation on sympathetic nervous system regulation in a clinical setting. Indeed, patients in previous renal nerve ablation trials were on multiple medications. Drug withdrawal is difficult to justify in these patients given their high cardiovascular risk. Obviously, we cannot completely rule out that patients did not adhere to the prescribed treatment.
